The abstract is read at the publisher; the summary is JClub's.
Higher updated interval mean HbA1c is linked to increased mortality in individuals with CF-related diabetes in the UK Cystic Fibrosis Registry, with adjusted rate ratios up to 1.93.
- Why it matters: Mortality is elevated in CF-related diabetes, but the relationship between long-term glycemia and death risk has been unclear.
- What they did: Using UK Cystic Fibrosis Registry data (4,477 people; 31,311 person-years), Poisson regression estimated mortality rates and rate ratios across updated interval mean HbA1c, adjusting for age, sex, calendar year, BMI, pulmonary function, and CFTR modulator use.
- The result: Mortality rates rose progressively with higher HbA1c; compared with HbA1c ≤42 mmol/mol, adjusted rate ratios were 1.41, 1.66, and 1.93 for HbA1c >42–53, >53–69, and >69 mmol/mol, respectively.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.